New Key Statistics Module, Z-Score and F-Score
SZSE:000513 Key Ratios
Market Cap ¥ M | 28,321.53 |
Enterprise Value ¥ M | 21,107.91 |
P/E(ttm) | 16.35 |
PE Ratio without NRI | 14.58 |
Forward PE Ratio | 15.23 |
Price/Book | 2.34 |
Price/Sales | 2.71 |
Price/Free Cash Flow | 11.40 |
Price/Owner Earnings | 25.74 |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 12,022.00 |
EPS (TTM) ¥ | 2.15 |
Beneish M-Score | -2.85 |
10-y EBITDA Growth Rate % | 13.20 |
5-y EBITDA Growth Rate % | 12.70 |
y-y EBITDA Growth Rate % | 6.30 |
EV-to-EBIT | 7.91 |
EV-to-EBITDA | 7.91 |
PEG | 1.15 |
Shares Outstanding M | 926.38 |
Net Margin (%) | 16.55 |
Operating Margin % | 21.44 |
Pre-tax Margin (%) | 21.36 |
Quick Ratio | 1.60 |
Current Ratio | 1.81 |
ROA % (ttm) | 7.88 |
ROE % (ttm) | 14.29 |
ROIC % (ttm) | 20.09 |
Dividend Yield % | 3.85 |
Altman Z-Score | 3.34 |
SZSE:000513 Number of Guru Trades
SZSE:000513 Volume of Guru Trades
Gurus Latest Trades with SZSE:000513
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:000513 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Livzon Pharmaceutical Group Inc Insider Transactions
No Available Data